Drug controller general of india - Latest News Update, Information, Photos & Videos on Drug controller general of india at Lokmat Times

The Drug Controller General of India has given its approval to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population to check whether the vaccine gives a similar immune response in trials similar to what it has shown on the Russian population.A Subject Expert Committee (SEC) meeting held on August 5 recommended the trial condition based on the efficacy of the vaccine also to be evaluated on the 42nd, 90th, and 180th day following the second dose."Interim analysis can be conducted on day 42 as this data was generated during the Sputnik V trials in India after the first dose, which was stated to be available up to day 21," reads the minutes of the SEC meeting.Earlier in the month of April, the two-dose version of the vaccine, Sputnik V, was approved for 'emergency use' by the Drugs Controller General of India (DCGI).According to Dr V K Paul, Member (Health), NITI Aayog, till now 8- 9 lakh doses of Sputnik V has been administered in India.Sputnik Light, which is the first dose of the original two-dose composition, has shown the efficacy of 79 per cent.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Drug Controller General Of IndiaFOLLOW

Drug controller general of india, Latest News

New Delhi, Feb 12 Traders' body the Confederation of All India Traders (CAIT) has lauded the issuance of ... ...

The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group. ...

The Drug Controller General of India (DGCI) on Friday gave permission to Bharat Biotech for intranasal booster dose trials. ... ...

Vaccination is currently gaining momentum across the country to fight the corona pandemic. Covishield and Covaxin vaccines are currently ... ...

Corona vaccination has been started for minors between the ages of 15 and 18 in the country. So far, ... ...

Hyderabad, Dec 28 Bharat Biotech is targeting to make one billion doses of its Covid-19 intranasal vaccine annually ... ...

The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesd ...

The Drug Controller General of India has given its approval to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population to check whether the vaccine gives a similar immune response i ...